Manufacturing

Apr 10, 2018
By Pharmaceutical Technology Editors
The new 300,000-square-foot facility is considered the largest dedicated cell and gene therapy manufacturing facility with fully integrated services.
Apr 09, 2018
By Pharmaceutical Technology Editors
Celltrion received complete response letters from FDA for its rituximab and trastuzumab biosimilars.
Apr 09, 2018
By Pharmaceutical Technology Editors
Under this global collaboration, the companies will develop encapsulated cell therapies for treating Type 1 diabetes.
Apr 05, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
The active pharmaceutical ingredient and excipient provider has expanded its parenteral ingredient manufacturing capacity and lab services.
Apr 05, 2018
By Pharmaceutical Technology Editors
Fujifilm acquires cell culture media companies Irvine Scientific Sales Company and IS Japan.
Apr 05, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
The contract development and manufacturing organization announced the addition of a new building complex that will house its headquarters in Bothell, WA.
Apr 05, 2018
By Pharmaceutical Technology Editors
The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.
Apr 05, 2018
By Pharmaceutical Technology Editors
Colorcon Inc. and Applied DNA signed a supply agreement granting Colorcon exclusive right to use Applied DNA’s SigNature molecular tags in film coatings for solid oral dosage forms, and non-exclusive rights to use it in inks and colorants for SOD pharmaceuticals.
native1_300x100
lorem ipsum